Molecular Devices Overview
- Year Founded
-
1983
- Status
-
Acquired/Merged
- Employees
-
1,200
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
9
Molecular Devices General Information
Description
Developer of bio-analytical measurement systems based in San Jose, California. The company specializes in engineering, molecular, cell biology and chemistry and develops proprietary core technologies and platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection, providing customers with bioanalytical solutions for protein and cell biology in life science research, pharmaceutical and biotherapeutic development.
Contact Information
Website
www.moleculardevices.com(Operating Subsidiary)
Corporate Office
- 3860 North First Street
- San Jose, CA 95134
- United States
Corporate Office
- 3860 North First Street
- San Jose, CA 95134
- United States
Molecular Devices Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Molecular Devices Comparisons
Industry
Financing
Details
Molecular Devices Competitors (25)
One of Molecular Devices’s 25 competitors is Standard BioTools, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
| Nexcelom Bioscience | Formerly PE-Backed | Lawrence, MA | ||||
| SPT Labtech | Private Equity-Backed | Melbourn, United Kingdom | ||||
| Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| NanoString Technologies | Formerly VC-backed | Seattle, WA |
Molecular Devices Patents
Molecular Devices Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240331158-A1 | Cell painting and analysis in 3d cellular models | Pending | 30-Mar-2023 | ||
| EP-4493670-A1 | Cell culture application methods of using a separation well microplate | Pending | 18-Mar-2022 | ||
| EP-4453544-A1 | Microplate reader | Pending | 24-Dec-2021 | ||
| US-20240069322-A1 | Methods and systems to compensate for substrate thickness error | Pending | 05-Jan-2021 | ||
| EP-4275088-A1 | Methods and systems to compensate for substrate thickness error | Pending | 05-Jan-2021 | G02B21/0088 |
Molecular Devices Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Molecular Devices Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Molecular Devices Investments & Acquisitions (9)
Molecular Devices’s most recent deal was a Merger/Acquisition with Cellesce. The deal was made on 06-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cellesce | 06-Dec-2022 | Merger/Acquisition | Drug Discovery | ||
| Genetix Group (Drug Discovery Division) | 05-Jul-2011 | Merger/Acquisition | Drug Discovery | ||
| Blueshift Biotechnologies | 27-Jun-2008 | Merger/Acquisition | Diagnostic Equipment | ||
| Arcturus Bioscience | 01-Apr-2006 | Merger/Acquisition | Decision/Risk Analysis | ||
| Xsira Pharmaceuticals (Transfluor technology) | 09-Mar-2005 | Corporate Asset Purchase | Buildings and Property |
Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cellesce | Cardiff, United Kingdom | 2013 |
Molecular Devices FAQs
-
When was Molecular Devices founded?
Molecular Devices was founded in 1983.
-
Where is Molecular Devices headquartered?
Molecular Devices is headquartered in San Jose, CA.
-
What is the size of Molecular Devices?
Molecular Devices has 1,200 total employees.
-
What industry is Molecular Devices in?
Molecular Devices’s primary industry is Discovery Tools (Healthcare).
-
Is Molecular Devices a private or public company?
Molecular Devices is a Private company.
-
What is Molecular Devices’s current revenue?
The current revenue for Molecular Devices is .
-
How much funding has Molecular Devices raised over time?
Molecular Devices has raised $57.8M.
-
Who are Molecular Devices’s investors?
Alafi Capital Company, Chase Bank, Glynn Capital, Kopp Investment Advisors, and Liberty Ridge Capital are 5 of 8 investors who have invested in Molecular Devices.
-
Who are Molecular Devices’s competitors?
Standard BioTools, Nexcelom Bioscience, SPT Labtech, Sphere Fluidics, and NanoString Technologies are some of the 25 competitors of Molecular Devices.
-
When was Molecular Devices acquired?
Molecular Devices was acquired on 01-Feb-2010.
-
Who acquired Molecular Devices?
Molecular Devices was acquired by Danaher.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
